We understand that each partner has different needs and internal capabilities. Working with IDSU enables our partners to access WuXi’s industry-leading capability and technology platform in efficient and cost-effective ways. Our small-molecule platform spans the entire R&D value chain – from discovery to commercialization. Our laboratory services extend from in-depth discovery chemistry and biology to preclinical development, including GLP toxicology and bioanalytical. Development and manufacturing services range from formulation and analytical R&D to GMP clinical drug product and commercial API manufacturing at our STA subsidiary. WuXi’s Genome Center tackles challenges in personalized medicine, while clinical and regulatory services support our partners’ needs to conduct the highest-quality clinical trials in China for Chinese and international regulatory filings.